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Introduction {#sec1}
============

Fragile X mental retardation protein (FMRP) is an RNA-binding protein, loss of which leads to fragile X syndrome ([@bib35]). FMRP is recognized as a translation modulator, and its role in metabotropic glutamate receptor (mGluR) signaling is extensively studied. Dysregulated synaptic translation in the absence of FMRP is thought to be responsible for majority of the phenotypes in fragile X syndrome ([@bib3], [@bib29], [@bib30], [@bib33]). FMRP is also shown to have an important role in neuronal development particularly during neuronal differentiation. The absence of FMRP is reported to affect the maintenance of pluripotency, cell fate choice and rate of progression to the neuronal lineages both in animal and human stem cell models ([@bib24], [@bib25], [@bib44]). Thus, FMRP-mediated regulation of translation is likely to be more global than confined to the synapse. However, the mechanism of FMRP-mediated translation regulation beyond the synapse is not understood.

FMRP is present in the cytosol as well as in the nucleus and localizes to the distal compartments in neurons. A significant amount of FMRP has been reported to be present in the nuclear and nucleolar compartments in neurons and other cell types ([@bib10], [@bib13], [@bib14], [@bib19], [@bib43]). However, the function of FMRP in nucleus still remains unexplained. Since it has both nuclear localization and nuclear export signals, FMRP is proposed to be involved in the shuttling of its target mRNAs between the nucleus and cytosol ([@bib19]). A mutation in the nuclear localization signal was also reported to cause fragile X-like syndrome ([@bib8]). In addition, there is an intriguing possibility that FMRP might interact with a distinct class of RNA in the nuclear/nucleolar compartments and play a crucial role in global translation regulation.

Translational regulation by FMRP has been reported through its direct interaction with the 60S subunit of the ribosome ([@bib7], [@bib18]). A mutation affecting FMRP\'s interaction with ribosomes leads to a severe form of mental retardation ([@bib12], [@bib31]), whereas its interaction with mRNAs is not affected by this mutation. According to these evidences, we postulate that FMRP has an important function in the nucleus, which could modulate its function in the cytoplasm. Here, we report an interesting interaction of FMRP with a subset of small nucleolar RNAs (snoRNAs) in the nuclear compartment of human embryonic stem cells (hESCs) and neuronal precursor cells (hNPCs) derived from these hESCs. FMRP\'s interaction with snoRNAs contributes to differential methylation of rRNA, generating ribosome heterogeneity. The absence of FMRP results in an alteration of this methylation pattern. On the other hand, FMRP also recognizes specific methylation patterns on rRNA and hence marks a subset of ribosomes. Our results identify a nuclear function of FMRP and imply that it can integrate translation regulation between the nucleus and cytoplasm.

Results and Discussion {#sec2}
======================

FMRP Interacts with a Selected Subset of snoRNAs {#sec2.1}
------------------------------------------------

To investigate the small RNAs that interact with FMRP during neuronal development, we used human H9 hESCs and H9 neuronal precursor cells (hNPCs) as our model system. H9 hESCs were characterized for pluripotency by immunocytochemistry with the marker OCT4 ([Figure 1](#fig1){ref-type="fig"}A), and similarly, hNPCs were characterized for the expression of Nestin ([Figure 1](#fig1){ref-type="fig"}B). In H9 hESCs, we show that FMRP interacts with AGO2, a primary component of the miRNA induced silencing complex (miRISC) ([Figure 1](#fig1){ref-type="fig"}C) indicating its interaction with microRNA machinery. In our initial observations, other than microRNA, we found another class of RNA (80--100nt) predominantly present in the FMRP immunoprecipitates. To identify this unknown class of small RNAs, we performed an FMRP immunoprecipitation (IP) with H9 hESCs and hNPCs followed by small RNA library preparation from both the microRNA band (30--50 nt) and the higher-molecular-weight band (80--100 nt). An AGO2 IP was used as a positive control to profile the microRNAs ([Figure 1](#fig1){ref-type="fig"}D). The libraries were separated on a 6% polyacrylamide gel and showed a prominent band in AGO2 IP at a size of 140 bp representing the population of microRNAs ([Figure 1](#fig1){ref-type="fig"}D).Figure 1FMRP Interacts with Selected Set of C/D Box snoRNAs in Human ESCs and NPCs(A) Characterization of H9 hESCs with pluripotency marker OCT4 and nuclear marker DAPI (scale bar, 50 μm).(B) Characterization of H9 hNPCs with differentiation marker Nestin and nuclear marker DAPI (scale bar, 50 μm).(C) Immunoblot for FMRP and AGO2 from H9 hESC lysate after FMRP and IgG immunoprecipitation.(D) Polyacrylamide gels showing mobility of cDNA libraries prepared from RNA extracted after immunoprecipitation with FMRP and AGO2 from H9 hESC and hNPC lysate.(E) Schematic showing the experimental workflow to identify FMRP-associated small RNAs.(F) Pie chart showing the distribution of different classes of small RNAs from the sequence obtained from the 200-bp band of the library from H9 hESCs, n = 3.(G) Pie chart showing the distribution of different classes of small RNAs from the sequence obtained from the 200-bp band of the library from H9 hNPCs, n = 3.(H) Principal component analysis (PCA) chart indicating clustering of snoRNA libraries in H9 hESCs and H9 hNPCs, hESC FMRP IP n = 3, hNPC FMRP IP n = 3, hESC Input n = 1, and hESC AGO2 IP n = 2.

Surprisingly, the prominent band in FMRP IP was identified at a much higher size (around 200 bp) ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}A). We isolated the bands corresponding to both 140 and 200 bp from the FMRP IP samples and sequenced them separately ([Figure 1](#fig1){ref-type="fig"}E). We have included a mouse IgG control in this experiment, and since there was insignificant RNA precipitated with this ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}B) compared to FMRP IP, it was not further considered for preparation of cDNA library. The band corresponding to 140 bp in FMRP IP majorly contained microRNAs (data not shown) similar to that in the AGO2 IP. Interestingly, the major component of the 200-bp band (corresponding to 80--100 nt RNAs) from the library was C/D box snoRNAs ([Figures 1](#fig1){ref-type="fig"}F and 1G). In contrast, AGO2 IP from hESCs and hNPCs showed negligible amount of snoRNA ([Figures S1](#mmc1){ref-type="supplementary-material"}D and S1E) compared with the input ([Figure S1](#mmc1){ref-type="supplementary-material"}C). The library profile of the 200-bp band (corresponding to snoRNA) derived from FMRP IP was similar in both hESCs and hNPCs as depicted by the principal-component analysis plot ([Figure 1](#fig1){ref-type="fig"}H). Top snoRNAs associated with FMRP in hESCs are listed in [Table S1](#mmc1){ref-type="supplementary-material"}, and all these snoRNAs are predicted to target and methylate specific sites on 18S or 28S ribosomal RNA.

We validated the interaction of FMRP with snoRNA by performing qPCR for the snoRNAs that were highly enriched in the FMRP IP from H9 hESC lysate ([Figure 2](#fig2){ref-type="fig"}A). Our qPCR primers were designed such that an entire snoRNA was amplified from the FMRP IP, suggesting that FMRP interacts with the mature snoRNA (as determined by the sequencing data) rather than the products derived from their further processing ([@bib5], [@bib42]). All the selected snoRNA candidates showed a significant enrichment in FMRP IP (pellet/input ratio), compared with the corresponding IgG control ([Figure 2](#fig2){ref-type="fig"}A). In contrast, none of the snoRNAs were enriched in the AGO2 pellet ([Figure S2](#mmc1){ref-type="supplementary-material"}B). The small fraction of snoRNA (5%) found in the AGO2 pellet ([Figure S1](#mmc1){ref-type="supplementary-material"}D) could be small RNA derived from further snoRNA processing. The mature full-length snoRNA we tested for were absent in this sample. To confirm that FMRP\'s interaction with these snoRNAs is specific, we performed IP with an antibody against a different epitope of FMRP ([Figure S2](#mmc1){ref-type="supplementary-material"}A). We further validated FMRP\'s interaction with target snoRNAs in a different human ESC line (Shef4) ([Figure S2](#mmc1){ref-type="supplementary-material"}C) and in HeLa cells ([Figure 2](#fig2){ref-type="fig"}B) as well. Our results indicate that the interaction of FMRP with snoRNAs is a common feature among all the cell types we tested.Figure 2Validation of FMRP Interaction with C/D Box snoRNA(A) Validation of FMRP-interacting snoRNA in human H9 hESCs by qPCR with representative immunoblot for FMRP IP (n = 6, unpaired Student\'s t test, mean ± SEM).(B) Validation of FMRP-interacting snoRNA in HeLa cells by qPCR with representative immunoblot for FMRP IP (n = 4, unpaired Student\'s t test, mean ± SEM). Also refer [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.(C) Electrophoretic mobility shift assay showing shift in mobility of radiolabeled SNORD80 by increasing concentration of His-FMRP. Lane 8 shows a complete abolishment of shift with molar excess of unlabeled (cold) SNORD80 RNA. Lanes 9 and 10 indicated no change in the mobility of His-FMRP with radiolabeled non-specific bacterial RNA. Samples in lanes 9 and 10 were run on a separate gel.

FMRP Directly Interacts with C/D Box snoRNA {#sec2.2}
-------------------------------------------

Our next objective was to test whether FMRP directly interacts with C/D box snoRNAs. To study this, we performed an electrophoretic mobility shift assay with purified full-length human FMRP ([Figure S2](#mmc1){ref-type="supplementary-material"}D). For this we chose SNORD80, one of the top snoRNA candidates which we found to be associated with FMRP in our high-throughput analysis ([Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). SNORD80 was radiolabeled with γ-P-ATP and was incubated with increasing concentrations of FMRP (from 100 nM to 14.6 μM). We observed a shift in SNORD80 mobility even with an FMRP concentration of 500 nM ([Figure 2](#fig2){ref-type="fig"}C), which was further enhanced in a concentration-dependent manner, indicating a direct interaction of SNORD80 with FMRP. The shift in SNORD80 mobility was completely reversed by incubation with molar excess of unlabeled SNORD80 ([Figure 2](#fig2){ref-type="fig"}C-lane 8). This competition was seen only with unlabeled SNORD80 and not with nonspecific bacterial RNA (lane 9 and 10) along with yeast tRNA, which was used in all other lanes thus confirming the specific interaction of SNORD80 with FMRP. Although we demonstrate the direct interaction of FMRP with one of the candidate snoRNAs, we cannot rule out the possibility that FMRP\'s interaction with C/D box snoRNAs may also be mediated through other snoRNP components or other nuclear FMRP interacting proteins such as NUFIP1 ([@bib2]).

Among the two major classes of snoRNAs involved in rRNA modifications (C/D box snoRNAs that mediate 2-O\'methylation and H/ACA box snoRNAs that mediate pseudo-uridylation) ([@bib11], [@bib15]), we detected only C/D box snoRNAs in the FMRP pellet. We did see a weak higher-molecular-weight band in the cDNA library prepared from the FMRP pellet ([Figure S1](#mmc1){ref-type="supplementary-material"}A); however, we did not find any H/ACA box snoRNA or precursor snoRNA when we sequenced this band (data not shown). Thus, FMRP appears to interact only with C/D box snoRNA, although we cannot completely rule out an interaction with H/ACA box snoRNA in the FMRP pellet. Since H/ACA box snoRNAs possess complex secondary structures, there is a possible bias against them in the cDNA library preparation.

The specific interaction with C/D box snoRNAs indicates that FMRP seems to have an important role in rRNA methylation. These C/D box snoRNAs primarily guide the 2'O methylation on selected ribose sugars on rRNA, which is important for the folding of the rRNA and the assembly of ribosomal proteins ([@bib11], [@bib36]). Some snoRNAs are also reported to generate smaller RNAs, including microRNAs ([@bib5]), found in the cytoplasm. Here, we show that FMRP\'s interaction with snoRNAs is only confined to the nuclear fraction ([Figure 3](#fig3){ref-type="fig"}G). Also, it interacts with full-length snoRNAs and not the processed small RNA products of snoRNAs.Figure 3Interaction of Nuclear FMRP with C/D Box snoRNA(A) Immunostaining of H9 hESCs (blue-DAPI, red-FMRP, and scale bar, 5 μm) followed by segmented images showing nuclear distribution of FMRP (scale bar, 1 μm).(B) Quantification of nuclear FMRP in H9 hESCs, n = 29 cells.(C) Immunoblots showing the distribution of FMRP in H9 hESC nuclear and cytoplasmic fractions, Lamin as nuclear marker and Tubulin as cytoplasmic marker.(D) Immunoblots for FMRP and Fibrillarin followed by FMRP or Fibrillarin immunoprecipitation from nuclear fractions of H9 hESCs.(E) Immunoblots showing the distribution of FMRP in HeLa nuclear and cytoplasmic fractions with Lamin as nuclear marker and Tubulin as cytoplasmic marker.(F) Immunoblots for FMRP and Fibrillarin followed by FMRP or Fibrillarin immunoprecipitation from nuclear fractions of HeLa cells.(G) qPCR for selected snoRNAs after immunoprecipitation with FMRP from nuclear and cytoplasmic lysates of H9 hESCs. Values are the ratio of pellet/input of the cytoplasmic fraction normalized to the pellet/input ratio of the nuclear fraction (n = 3, unpaired Student\'s t test, mean ± SEM).

A group of snoRNAs without specific targets on rRNA (called orphan snoRNAs) are also known to have a role in mRNA splicing ([@bib20]). All top snoRNA candidates precipitated with FMRP have predicted target sites on rRNA, and we did not find any orphan snoRNA enriched in the pellet ([Table S1](#mmc1){ref-type="supplementary-material"}). These results clearly suggest that the interaction of FMRP with snoRNA is likely to have a role in rRNA methylation.

Interaction with snoRNA Is a Function of Nuclear FMRP {#sec2.3}
-----------------------------------------------------

Although FMRP is often studied as a cytoplasmic protein, it has a nuclear localization signal, and its localization to the nucleus is reported by several studies ([@bib19], [@bib43]). Here we show a localization of FMRP in the nucleus of H9 hESCs ([Figure 3](#fig3){ref-type="fig"}A) by FMRP immunostaining overlaid with DAPI, a nuclear marker. Similarly, we observed FMRP\'s localization in the nucleus of Neuro2A ([Figure S3](#mmc1){ref-type="supplementary-material"}A), HeLa ([Figure S3](#mmc1){ref-type="supplementary-material"}B), rat cortical neurons ([Figure S3](#mmc1){ref-type="supplementary-material"}C), and rat astrocytes ([Figure S3](#mmc1){ref-type="supplementary-material"}D) confirming that FMRP is present both in the nucleus and cytoplasm of the all the cell types that we studied. We quantified the percentage of FMRP in the nucleus based on DAPI staining ([Figure 3](#fig3){ref-type="fig"}B) and found that nearly 50% of FMRP localized in the nucleus of hESCs. Since the nucleus of ESCs is relatively large, we expect the ratio of nuclear to cytoplasmic FMRP to be lower in other cell types ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3D). We also confirmed that FMRP\'s localization in the nucleus is specific through immunostaining with an antibody raised against a different epitope of FMRP ([Figure S3](#mmc1){ref-type="supplementary-material"}E). To establish the compartment-specific localization of FMRP, we used nuclear and cytoplasmic fractions from H9 hESCs ([@bib4]) and probed for the presence of FMRP. The purity of the fractionation was validated by LaminB1 and α-Tubulin as nuclear and cytoplasmic markers respectively ([Figure 3](#fig3){ref-type="fig"}C). FMRP was found to be present in both nuclear and cytoplasmic fractions ([Figure 3](#fig3){ref-type="fig"}C).

The sequence between the C and D′ box (or C′ and D) is complementary to a specific region on rRNA, and this complementarity determines the site to be methylated ([@bib6]). RNA-binding proteins forming the snoRNP complex are recruited to these sites by C/D box snoRNAs, and 2'O-methylation is carried out by a nucleolar-specific methyltransferase, Fibrillarin ([@bib39]). Since FMRP has a putative nucleolar localization signal and has been shown to localize to the nucleolus ([@bib43]), we tested whether it interacts with Fibrillarin. For this, we probed for the presence of Fibrillarin in FMRP immunoprecipitates from the nuclear fraction of H9 hESCs. We did not see a co-precipitation of Fibrillarin with FMRP ([Figure 3](#fig3){ref-type="fig"}D). Similarly, we did not see FMRP in the Fibrillarin immunoprecipitate ([Figure 3](#fig3){ref-type="fig"}D). We tested for this interaction in nuclear extracts of HeLa ([Figures 3](#fig3){ref-type="fig"}E and 3F) and Neuro2A ([Figure S3](#mmc1){ref-type="supplementary-material"}F) and did not find FMRP co-precipitating with Fibrillarin in any of these experiments. These results strongly suggest that FMRP and Fibrillarin are likely to be present in separate RNPs, although both interact with snoRNA. Finally, to confirm that the interaction of FMRP with snoRNA is in the nucleus, we performed an FMRP IP from H9 hESC nuclear and cytoplasmic fractions followed by qPCR for selected target snoRNAs. We found that these snoRNAs are significantly enriched in immunoprecipitates from nuclear fractions compared with cytoplasmic fractions ([Figures 3](#fig3){ref-type="fig"}G and [S3](#mmc1){ref-type="supplementary-material"}G). Thus, FMRP-snoRNA interaction is primarily in the nuclear compartment and seems to be distinct from Fibrillarin-containing snoRNPs. FMRP may sequester specific snoRNAs and control their availability to rRNA methylation machinery and regulate the extent of methylation. Similarly, other RNA-binding proteins might be involved in regulating rRNA methylation through their interaction with snoRNAs cumulatively leading to the differential rRNA methylation.

Differential 2\'O-Methylation of rRNA in Human ESCs {#sec2.4}
---------------------------------------------------

So far 106 methylation sites have been identified on human rRNA ([@bib11], [@bib16], [@bib26]). Recently it was reported that the differential methylation of selected sites on rRNA can give rise to ribosome heterogeneity as demonstrated in HeLa cells ([@bib21]). To establish the differential rRNA methylation in human ESCs, we estimated the extent of rRNA methylation of known sites in Shef4 hESCs using the recently developed high-throughput RiboMeth sequencing method ([@bib27]). In this method, ribosomal RNA extracted from hESCs was subjected to partial alkaline hydrolysis, followed by library preparation and sequencing (See [Transparent Methods](#mmc1){ref-type="supplementary-material"} section). The sequenced data were analyzed to estimate the extent of methylation using a previously described ([@bib21]) bioinformatics pipeline ([Figure S4](#mmc1){ref-type="supplementary-material"}A). In our assay we detected 97 sites in Shef4 hESC rRNA. A majority of the sites are completely methylated (methylation index close to 1); however, 9 sites on 18S rRNA ([Figure 4](#fig4){ref-type="fig"}A) and 15 sites on 28S rRNA were only partially methylated (methylation index significantly lower than 1) ([Figure 4](#fig4){ref-type="fig"}B) as reflected in [Table S3](#mmc1){ref-type="supplementary-material"}. The extent of methylation on these sites varied from a methylation index of 0.6 to 0.9 ([Figures 4](#fig4){ref-type="fig"}A and 4B), which denotes that these sites are methylated in 60%--90% of the ribosomes, whereas they are unmethylated in the remaining 10%--40% of the ribosomes. The heterogeneity of rRNA methylation we observed in hESCs is distinct from that of HeLa cells as reported previously ([@bib21]).Figure 4Ribosomal RNA 2\'O-Methylation Pattern in Shef4 and Shef4 *FMR1* KO hESCs(A) Methylation index of the sites on 18S rRNA in Shef4 hESCs. The x axis represents the respective methylation position on 18S rRNA, and y axis represents the fraction methylated, n = 3.(B) Methylation index of the sites on 28S rRNA in Shef4 hESCs. The x axis represents the respective methylation position on 28S rRNA, and y axis represents the fraction methylated, n = 3.(C) Immunoblots showing absence of FMRP in Shef4 *FMR1* KO hESCs with Tubulin as the control.(D) Change in levels of top snoRNA candidates in Shef4 WT and Shef4 *FMR1* KO hESCs by qPCR (n = 5, unpaired Student\'s t test, mean ± SEM).(E) Sites in 18S and 28S rRNA that show 5% or more difference in the methylation index between Shef4 hESCs and Shef4 *FMR1* KO hESCs (n = 3, mean ± SEM).

Absence of FMRP Alters the rRNA 2\'O-Methylation Pattern in Human ESCs {#sec2.5}
----------------------------------------------------------------------

We observe that FMRP interacts with a specific subset of C/D box snoRNAs ([Table S1](#mmc1){ref-type="supplementary-material"}), and we wanted to test if the absence of FMRP will have any effect on the level of its target snoRNAs at steady state. For this we generated Shef4 *FMR1* knockout (KO) hESCs using the CRISPR-Cas9 system ([Figures 4](#fig4){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}B--S4E) and performed a qPCR for these candidate snoRNAs. Surprisingly, at steady state, we did not see any significant change in the level of FMRP target snoRNAs in *FMR1* KO cells ([Figure 4](#fig4){ref-type="fig"}D). Since most of the snoRNAs we found associated with FMRP were C/D box snoRNA, we studied the impact of this interaction (FMRP-snoRNA) by looking at 2'O methylation in Shef4 wild-type (WT) and Shef4 *FMR1* KO hESCs ([Figures 4](#fig4){ref-type="fig"}E, [S4](#mmc1){ref-type="supplementary-material"}F, and S4G). We performed a high-throughput RiboMethSeq from WT and *FMR1* KO hESCs as described previously. On comparing the methylation profile between WT and KO cells, we found that the sites that were fully methylated in WT (methylation index 1) were unaffected in the absence of FMRP ([Figures S4](#mmc1){ref-type="supplementary-material"}F and S4G). Interestingly, many sites in 18S and 28S rRNA that were partially methylated in WT hESCs were significantly altered in the absence of FMRP ([Figure 4](#fig4){ref-type="fig"}E and [Table S3](#mmc1){ref-type="supplementary-material"}).

We independently validated the change in methylation of rRNA in the absence of FMRP for selected sites ([Figure 5](#fig5){ref-type="fig"}A) by a qPCR-based method called RTL-P ([@bib9]) ([Figure S5](#mmc1){ref-type="supplementary-material"}A). RTL-P has been previously used to identify the differential methylation of rRNA ([@bib9]), and we have further tested the validity of this assay ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5G). This method involves the amplification of PCR products under high and low dNTP concentrations for each primer set. There are two forward primers, one positioned upstream (P1) and other downstream (P2) of the methylation site. Amplification was done using a reverse primer (P3) downstream of the methylation site ([Figure S5](#mmc1){ref-type="supplementary-material"}A). For RTL-P we have considered the smaller PCR product (from P2 and P3) as our control in both high and low dNTP conditions (since it is unaffected by methylation). Then we have quantified the larger PCR product (from P1 and P3) at similar conditions and normalized it to its respective smaller PCR product ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). Example of RTL-P analysis for a given site has been provided in [Transparent Methods](#mmc1){ref-type="supplementary-material"}. We have validated two selected sites 401 (complete methylation) and 4917 (partial methylation) through RTL-P. The PCR products were run on a gel, and the bands corresponding to the upstream product (\*) were selectively cut out and cloned into a bacterial vector ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C) for Sanger sequencing ([Figures S5](#mmc1){ref-type="supplementary-material"}F and S5G). Furthermore, we validated site 4917 in WT and in *FMR1* knockdown HeLa cells. We observe that the intensity of the amplicon generated for the knockdown samples under low dNTPs is lesser compared to that of the WT ([Figures S5](#mmc1){ref-type="supplementary-material"}D and S5E). Here, we clearly show that under low and high dNTP conditions, we observe the PCR reaction stopping downstream and upstream of the methylation site as expected ([Figures S5](#mmc1){ref-type="supplementary-material"}F and S5G).Figure 5Validation of Change in rRNA 2\'O-Methylation Pattern by FMRP(A) RTL-P for selected sites on 18S and 28S rRNA to show differences in methylation in Shef4 WT and Shef4 *FMR1* KO hESC lysate (n = 3, unpaired Student\'s t test, mean ± SEM).(B) Schematic for reverse transcription followed by PCR (RTL-P) on *FMR1* knockdown or FMRP overexpression in HeLa cells.(C) Representative immunoblots for FMRP showing its knockdown in HeLa cells with Tubulin as a control.(D--F) RTL-P for selected sites showing the change in 2'O-methylation on *FMR1* knockdown in HeLa cells (n = 3, unpaired Student\'s t test, mean ± SEM).(G) Representative immunoblots for FMRP showing overexpression of FLAG-FMRP in HeLa cells with Tubulin as a control.(H--J) RTL-P for selected sites showing the change in 2'O-methylation on overexpression of FLAG-FMRP in HeLa cells (n = 3, unpaired Student\'s t test, mean ± SEM).

We chose sites for RTL-P validation based on our high-throughput sequencing as well as sites that were targeted by our top snoRNA candidates. Our RTL-P results were similar to that of the RiboMethSeq. Sites 429, 2416 and 4917 are significantly hypo-methylated in *FMR1* KO compared to WT. Site 4307 was significantly hyper-methylated in *FMR1* KO, whereas the methylation on site 401 was unaltered ([Figure 5](#fig5){ref-type="fig"}A). Apart from these, we also show that site 3680 (targeted by FMRP associated SNORD88A) is significantly hyper-methylated in the *FMR1* KO, although there was no difference in RiboMethSeq ([Figure 5](#fig5){ref-type="fig"}A). These results confirm that absence of FMRP has a significant impact on the methylation status of specific rRNA sites.

Heterogeneity among ribosomes is an emerging concept and provides a new dimension for translation regulation ([@bib22], [@bib38]). Modifications on rRNA, including snoRNA-guided methylation, are proposed to play an important role in contributing to heterogeneity ([@bib11]). However, the mechanism by which differential modification of rRNA occurs is not explored. Our work for the first time defines an interaction of an RNA-binding protein, FMRP, with a specific subset of C/D box snoRNAs. This interaction may have an influence in regulating rRNA methylation in humans. In the absence of FMRP, methylation was altered for 12 (5 on 18S rRNA and 7 on 28S rRNA) of 28 differentially methylated sites as identified by RiboMethSeq. Interestingly, sites that show an altered methylation in the absence of FMRP are the ones that also show partial methylation in the control (WT) hESCs (methylation index less than 1). This implies that FMRP has an important role in differential methylation of rRNA and has a significant contribution in generating ribosome heterogeneity.

Acute Knockdown or Overexpression of FMRP Alters rRNA 2\'O-Methylation Pattern {#sec2.6}
------------------------------------------------------------------------------

To verify that the change in 2'O-methylation observed is FMRP specific, we acutely knocked down FMRP (48 hr with siRNA, [Figures 5](#fig5){ref-type="fig"}B, 5C, and [S5](#mmc1){ref-type="supplementary-material"}H) and overexpressed FLAG-FMRP (24 hr [Figures 5](#fig5){ref-type="fig"}H and [S5](#mmc1){ref-type="supplementary-material"}I) in HeLa cells. Following FMRP knockdown or overexpression, we estimated the methylation of rRNA on selected sites through RTL-P ([Figures 5](#fig5){ref-type="fig"}D--5F and 5H--5J). On acute knockdown of FMRP, we observed hypo-methylation on the sites 2416, 4456, and 4917 ([Figure 5](#fig5){ref-type="fig"}E). The hypo-methylation of these sites on FMRP knockdown is the same as we have identified in *FMR1* KO hESCs both by high-throughput RiboMethSeq ([Figure 4](#fig4){ref-type="fig"}E) and RTL-P-based analysis from the same cells ([Figure 5](#fig5){ref-type="fig"}A). Sites 2788 and 4307, which showed hyper-methylation in *FMR1* KO hESCs, also showed hyper-methylation on acute knockdown of FMRP in HeLa cells ([Figure 5](#fig5){ref-type="fig"}F). These results confirm that the change in methylation in *FMR1* KO hESCs could be reproduced by acute knockdown of FMRP. In contrast, the effect of acute overexpression of FMRP was more complex. One of the sites (176), which showed hyper-methylation in *FMR1* KO hESCs ([Figure 4](#fig4){ref-type="fig"}E), showed a hypo-methylation on FMRP overexpression ([Figure 5](#fig5){ref-type="fig"}I) in HeLa cells. Similarly, a site (4917) that showed hypo-methylation in *FMR1* KO hESCs showed hyper-methylation on FMRP overexpression ([Figure 5](#fig5){ref-type="fig"}J), clearly indicating that the presence or absence of FMRP is the direct cause of change in methylation. Site 401, which was unaffected in *FMR1* KO hESCs, remained unchanged (with respect to its methylation) on FMRP knockdown or overexpression in HeLa cells ([Figures 5](#fig5){ref-type="fig"}D and 5H). Although acute knockdown of FMRP reproduces the results of *FMR1* KO, overexpression of FMRP has inconsistent effects. Overexpression may have limited effects owing to saturating concentration of endogenous FMRP.

Overall, our results indicate that absence of FMRP can lead to either hypo- or hyper-methylation on distinct sites. FMRP may sequester specific snoRNAs and control their availability to rRNA methylation machinery and regulate the extent of 2\'O-methylation. However, the role of FMRP in controlling status of methylation is unclear; identifying the other components (both protein and RNA) involved is needed to address this issue.

FMRP Recognizes Differential 2\'O-Methylation Pattern {#sec2.7}
-----------------------------------------------------

We have demonstrated that FMRP interacts with a subset of snoRNAs in the nuclear compartment. In the absence of FMRP, rRNA 2\'O-methylation is significantly altered and this affects ribosome heterogeneity. We also show that FMRP interacts with ribosomal proteins ([Figure 6](#fig6){ref-type="fig"}A) as also previously reported ([@bib7]) ([@bib40]). Based on these results we wanted to investigate if FMRP can recognize the 2\'O-methylation pattern on ribosomes. For this we performed FMRP immunoprecipitation and isolated rRNA, which was pulled down with FMRP. We quantified the extent of 2\'O-methylation of selected sites on rRNA by RTL-P and compared it with the extent of methylation to ribosomes in the input ([Figure 6](#fig6){ref-type="fig"}B). We chose the sites whose methylation is altered in the absence of FMRP. Among them, three sites showed a significant difference in the FMRP pellet compared to the input. Site 429 (18S rRNA) showed a trend of hyper-methylation in the FMRP pellet, whereas sites 2416 and 4917 (28S rRNA) were hypo-methylated compared to the input. Site 401 remained unchanged ([Figure 6](#fig6){ref-type="fig"}B). There was no difference in the methylation pattern for these sites in the control IP with IgG ([Figure S6](#mmc1){ref-type="supplementary-material"}B). These results indicate that FMRP binds to the ribosome preferentially when site 429 is methylated in 18S rRNA and 2416 and 4917 are unmethylated in 28S rRNA. Although we show that FMRP interacts with ribosomal proteins in the nuclear fraction ([Figure 6](#fig6){ref-type="fig"}A), currently we do not know whether this recognition of rRNA methylation pattern by FMRP happens during the assembly of ribosomes or later. Our initial experiments indicate that FMRP shows a better interaction with rRNA when it is from cell lysate rather than with purified rRNA ([Figure S6](#mmc1){ref-type="supplementary-material"}A).Figure 6Recognition of rRNA 2\'O-Methylation by FMRP(A) Immunoblots showing the presence of ribosomal protein RPLP0 in FMRP immunoprecipitate from H9 hESC nuclear fractions.(B) Relative methylation index of H9 hESC rRNA from FMRP IP normalized to input by RTL-P (n = 3--4, unpaired Student's t test, mean ± SEM).(C) Model illustrating the role of FMRP in regulating translation through differential rRNA methylation.

An interesting possibility is that the heterogeneity influenced by FMRP (in the form of differential rRNA methylation) is recognized by FMRP itself and thus recruits a subset of ribosomes for the translation of its own target mRNAs ([Figure 6](#fig6){ref-type="fig"}C-model). Our results indicate that FMRP recognizes differential 2\'O-methylation pattern on selected sites of rRNA. Interestingly, there are many G-quartet structures (an RNA motif recognized by FMRP) that lie in close proximity to these rRNA methylation sites, which might be regulated by FMRP ([Figure S6](#mmc1){ref-type="supplementary-material"}C). An altered methylation on these sites could influence the G-quartet structures, which interact with FMRP. We propose this to be the mechanism by which FMRP recognizes ribosomes based on differential rRNA methylation on specific sites ([Figure 6](#fig6){ref-type="fig"}C-model).

Limitations of the Study {#sec2.8}
------------------------

This study focused on the interaction of FMRP with C/D box snoRNA in the nucleus. Our data suggests that the interaction of FMRP with specific C/D Box snoRNA might affect 2'O-methylation on rRNA. At the mechanistic level, our data can correlate only the levels of FMRP and the consequent change in methylation of specific sites. We show that FMRP and Fibrillarin (rRNA-specific methyltransferase) are in separate complexes, and we do not know the exact molecular mechanism involving the FMRP-snoRNA complex and how it regulates changes in rRNA post-transcriptional modifications in a cell.

We know from our data that FMRP can bind to the ribosome, especially through the RNA component. We propose a putative model describing how the rRNA methylation pattern can be recognized by FMRP based on a bio-informatics prediction, but we currently do not have any experimental evidence to prove that. Our data demonstrates the link between FMRP\'s interaction with a subset of C/D box snoRNAs and rRNA methylation. Although we have evidence regarding the recognition of specific 2'O-methylation patterns by RNA binding proteins (RBPs) like FMRP, we are yet to understand the correlation between the role of FMRP in rRNA methylation, FMRP\'s recognition of specific methylation patterns, and translation regulation of specific subset of mRNAs, which is beyond the scope of our manuscript.

Methods {#sec3}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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